Recruiting NCT06261034

NCT06261034 A Study of Sex Differences in Neurocirculatory Control

◆ AI Clinical Summary

Plain-language summary for patients

Clinical Trial Summary
NCT ID	NCT06261034
Status	Recruiting
Phase	—
Sponsor	Mayo Clinic
Condition	Obstructive Sleep Apnea
Study Type	OBSERVATIONAL
Enrollment	60 participants
Start Date	2024-10-29
Primary Completion	2027-03

Trial Parameters

Condition Obstructive Sleep Apnea

Sponsor Mayo Clinic

Study Type OBSERVATIONAL

Phase N/A

Enrollment 60

Sex ALL

Min Age 20 Years

Max Age 70 Years

Start Date 2024-10-29

Completion 2027-03

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Your Age

Your Sex

Brief Summary

The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA).

Eligibility Criteria

Inclusion Criteria: * 20-70 years of age Exclusion Criteria: * Coronary artery disease * Heart failure * Pregnancy * COPD * Diabetes * CKD * Sleep disorders other than OSA * Shift workers * Individuals who typically go to sleep after midnight * Individuals who traveled across ≥2 time zones within one week of study visits * BMI ≥40.0kg/m2 * Use of nicotine-containing products within the two years preceding study visits * Use of allopurinol, proton pump inhibitors, or other medications/supplements which interfere with outcome measures

Related Trials

NCT06331819

Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.

View Trial →

NCT02784977

TURKAPNE - The Turkish Sleep Apnea Database: A National, Multicenter, Observational, Prospective Coh

View Trial →

NCT03924817

Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advanceme

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE OBSTRUCTIVE SLEEP APNEA TRIALS

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology